NCT06246916 2026-02-19A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Regeneron PharmaceuticalsPhase 3 Recruiting560 enrolled